Pureos Bioventures
Chief Medical Officer and Head of Research and Development of Voyager Therapeutics. Previously Global Head of Neuroscience Translational Medicine and Rare Diseases at Roche, and before that Chief Resident at Harvard Medical School. MD Ph.D. from the University of Cambridge, UK.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Pureos Bioventures
Pureos is a venture capital fund investing in private innovative drug development companies.